Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changsha Wanrun Bio-Technology is a high-tech enterprise based in China that specializes in the development and production of in vitro diagnostic (IVD) reagents and instruments. The company's core expertise lies in molecular diagnostics, particularly utilizing real-time PCR and nucleic acid extraction technologies. Their product catalog includes a wide array of detection kits for human pathogens such as SARS-CoV-2 and HPV, as well as significant veterinary diagnostics for livestock diseases like African Swine Fever. Beyond reagents, the company provides automated laboratory equipment designed to streamline diagnostic workflows in clinical and research settings. Wanrun Bio-Technology operates out of a modern manufacturing facility in Changsha and maintains various international quality certifications, including ISO 13485. Their solutions are widely deployed across hospitals, disease control centers, and animal health laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changsha Wanrun Bio-Technology.